Investment will enable company to expand its team to grow into new markets

London, 9 June, 2015 – Qinec, a pioneer in Personalised Healthcare Management, today announced that it has secured £6 million in Series B funding, led by Gilde Healthcare Partners, and including existing investors Amadeus Capital Partners and Archimedia.

Qinec personalises the delivery of healthcare, by using real-time data to orchestrate the patient journey resulting in optimal outcomes for patients, providers and payers whilst simultaneously reducing cost. Its cloud-based Personalised Healthcare Management (PHM) platform today supports millions of patient journeys a year across Europe.

Qinec will use the funding to scale the team and further expand the business to take advantage of a market predicted to be worth over $1.3 billion. This will enable the company, which counts Alliance Medical and Optegra Eye Health Care as customers, to grow more aggressively within the healthcare IT market.

Qinec has grown on average 100% year on year as commercial healthcare providers recognise that personalising healthcare benefits the patient experience while improving the effectiveness of healthcare delivery. Qinec helps providers deliver better quality of care at lower cost of provision. Qinec’s vision is that its platform will enable a world where the best possible healthcare outcome for every individual is assured.

Robbie Hughes, CEO and founder, Qinec commented: “Whilst every clinician would intuitively recognise that healthcare should be a personalised experience, delivering personalisation at scale has been impossible to date with different systems and stakeholders owning different parts of the patient journey. Qinec looks at the problem differently, providing a single platform to join up pathways across specialties and systems, giving visibility and control to providers ”

As part of the investment, Janke Dittmer, partner at Gilde Healthcare, joins the Board as a Non-Executive Director and Erik Masing as an Advisor. Additionally, Qinec is strengthening its executive team with the introduction of Andrew Wyatt as Chief Operating Officer. Andrew brings a depth of experience in successfully scaling software and SaaS businesses, including BroadSoft Inc (NASDAQ: BSFT) where he was VP Strategy and Apertio Ltd where he was Chief Product Operations Officer and interim CEO.

Janke Dittmer noted: “Healthcare providers are being challenged to provide better care at lower cost in an environment that is changing at an increasing pace. Qinec enables healthcare providers to adapt to the changing needs of patients, providers and payers.  We look forward to working with Qinec to successfully scale the business to address this clearly identified need.”

About Qinec
Qinec is a digital health company using real time data to personalise the patient journey for optimal healthcare outcomes.  We transform the quality of care provided whilst lowering the cost of healthcare delivery.

Our Personalised Healthcare Management (PHM) platform tailors processes and optimises clinical and administrative workflows to achieve optimal outcomes for patients, providers and payers.

Managing millions of patients a year across Europe, Qinec supports healthcare professionals by using real-time data to orchestrate the care journey. From scheduling and resourcing to outcome tracking and business intelligence, Qinec captures and transforms the patient journey across every specialty of outpatient care.

About Gilde Healthcare
Gilde Healthcare (Utrecht, The Netherlands and Cambridge, Massachusetts, US) is a private equity investor focused on fast growing healthcare businesses. It manages €550 million across two business lines. The Gilde Healthcare Technology funds target companies developing home & digital health solutions, medical devices and medicines in Europe and the USA. The Gilde Healthcare Services funds focus on healthcare service providers, such as specialist clinics, elderly care, primary care, mental health and other healthcare service providers in the Benelux and Germany. For a list of Gilde’s portfolio companies please visit the website at